Paola Fuso

Head Neck And Chest, Largo Agostino Gemelli 8
Rome, 00168, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Time Toxicity in Advanced Breast Cancer: Psychological Burden, Psychiatric Vulnerability, and Implications for Patient-Centered Decision-Making.

Time Toxicity in Advanced Breast Cancer: Psychological Burden, Psychiatric Vulnerability, and Implications for Patient-Centered Decision-Making.

Journal: Medicina (Kaunas, Lithuania)

Published: June 20, 2026

Insomnia in Breast Cancer: A Neglected Symptom Cluster.

Insomnia in Breast Cancer: A Neglected Symptom Cluster.

Journal: Journal of clinical medicine

Published: April 08, 2026

The Gut Microbiota in Perimenopausal Anxiety: A Novel Therapeutic Pathway Through Diet.

The Gut Microbiota in Perimenopausal Anxiety: A Novel Therapeutic Pathway Through Diet.

Journal: Nutrients

Published: December 27, 2025

Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK study.

Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK study.

Journal: Future oncology (London, England)

Published: June 14, 2025

Cognitive effects of aromatase inhibitors in early breast cancer patients: a prospective study.

Cognitive effects of aromatase inhibitors in early breast cancer patients: a prospective study.

Journal: Breast cancer research and treatment

Published: April 07, 2025

Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2.

Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2.

Journal: Critical reviews in oncology/hematology

Published: March 26, 2024

Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.

Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.

Journal: NPJ breast cancer

Published: February 05, 2024

TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication.

TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 27, 2023

Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.

Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.

Journal: NPJ breast cancer

Published: December 22, 2022

Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.

Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: August 30, 2022

BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making.

BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making.

Journal: Cancers

Published: July 31, 2022

PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives.

PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives.

Journal: Cancers

Published: March 22, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026